Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
MEDICINAL MARIJUANA - A COMPREHENSIVE REVIEW
Autore:
GURLEY RJ; ARANOW R; KATZ M;
Indirizzi:
SAN FRANCISCO DEPT PUBL HLTH,25 VAN NESS,SUITE 710 SAN FRANCISCO CA 94102
Titolo Testata:
Journal of psychoactive drugs
fascicolo: 2, volume: 30, anno: 1998,
pagine: 137 - 147
SICI:
0279-1072(1998)30:2<137:MM-ACR>2.0.ZU;2-X
Fonte:
ISI
Lingua:
ENG
Soggetto:
CANNABINOID RECEPTOR ANTAGONIST; T-CELL LINE; PRECIPITATED WITHDRAWAL; CANCER-CHEMOTHERAPY; MULTIPLE-SCLEROSIS; NMDA ANTAGONIST; INDUCED NAUSEA; DOUBLE-BLIND; ANANDAMIDE; HU-211;
Keywords:
CANNABINOIDS; CANNABIS; CLINICAL; MARIJUANA; REVIEW;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Physical, Chemical & Earth Sciences
Physical, Chemical & Earth Sciences
Citazioni:
114
Recensione:
Indirizzi per estratti:
Citazione:
R.J. Gurley et al., "MEDICINAL MARIJUANA - A COMPREHENSIVE REVIEW", Journal of psychoactive drugs, 30(2), 1998, pp. 137-147

Abstract

Considerable controversy exists regarding the role of marijuana as a therapeutic agent; however, many practitioners are taught very little about existing marijuana data. The authors therefore undertook a comprehensive literature review of the topic. References were identified using textbooks, review and opinion articles, and a primary literature review in MEDLINE. Sources were included in this review based primarilyon the quality of the data. Some data exists that lends credence to many of the claims about marijuana's properties. In general, however, the body of literature about marijuana is extremely poor in quality. Marijuana and/or its components may help alleviate suffering in patientswith a variety of serious illnesses. Health care providers can best minimize short term adverse consequences and drug interactions for terminally ill patients by having a thorough understanding of the pharmacology of marijuana, potential adverse reactions, infection risks, and drug interactions (along with on-going monitoring of the patient). For chronic conditions, the significance and risk of shea and long term adverse effects must be weighed against the desired benefit. Patients who are best suited to medicinal marijuana will be those who will gain substantial benefit to offset these risks, and who have failed a well-documented, compliant and comprehensive approach to standard therapies.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/09/20 alle ore 02:14:49